about
Therapeutic Strategies for Neuropathic Pain: Potential Application of Pharmacosynthetics and OptogeneticsThe therapeutic potential of genome editing for β-thalassemiaNon-embryo-destructive Extraction of Pluripotent Embryonic Stem Cells: Implications for Regenerative Medicine and Reproductive MedicineNeuroprotective therapies in glaucoma: II. Genetic nanotechnology toolsCell-based therapy technology classifications and translational challengesGene therapy for cardiovascular disease: advances in vector development, targeting, and delivery for clinical translationSpecific in vivo knockdown of protein function by intrabodiesState-of-the-art human gene therapy: part I. Gene delivery technologiesBacteriophage-derived vectors for targeted cancer gene therapyGene therapy for skin diseasesAdenovirus-mediated efficient gene transfer into cultured three-dimensional organoidsLiver-targeted gene therapy: Approaches and challengesTherapeutic genome editing: prospects and challengesHow (specific) would like your T-cells today? Generating T-cell therapeutic function through TCR-gene transferUltrasound-targeted hepatic delivery of factor IX in hemophiliac mice.Adverse health consequences of performance-enhancing drugs: an Endocrine Society scientific statement.Ultrasound directs a transposase system for durable hepatic gene delivery in miceGene therapy for Wiskott-Aldrich syndrome--long-term efficacy and genotoxicity.Glucose-containing diblock polycations exhibit molecular weight, charge, and cell-type dependence for pDNA delivery.Stimuli-Responsive Mesoporous Silica NPs as Non-viral Dual siRNA/Chemotherapy Carriers for Triple Negative Breast Cancer.Therapeutic genome editing by combined viral and non-viral delivery of CRISPR system components in vivoHuman Muscle Precursor Cells Overexpressing PGC-1α Enhance Early Skeletal Muscle Tissue FormationControlled Transcription of Exogenous mRNA in Platelets Using Protocells.Optimization of Polyplex Formation between DNA Oligonucleotide and Poly(ʟ-Lysine): Experimental Study and Modeling ApproachGene therapy for monogenic liver diseases: clinical successes, current challenges and future prospects.A new strategy to deliver synthetic protein drugs: self-reproducible biologics using minicircles.Next generation delivery system for proteins and genes of therapeutic purpose: why and how?In vivo genome editing using Staphylococcus aureus Cas9Niemann-Pick C1 affects the gene delivery efficacy of degradable polymeric nanoparticles.Pharmacological chaperones in the age of proteomic pathology.Multi-layered nanoparticles for combination gene and drug delivery to tumors.Gamma-retroviral vector design for the co-expression of artificial microRNAs and therapeutic proteins.Aging and brain rejuvenation as systemic events.Transgene detection by digital droplet PCRCombination of antibody targeting and PTD-mediated intracellular toxin delivery for colorectal cancer therapyNew approaches to the design and discovery of therapies to prevent erectile dysfunction.Non viral vectors in gene therapy- an overview.Development of Gene Transfer for Induction of Antigen-specific Tolerance.Non-viral immune electrogene therapy induces potent antitumour responses and has a curative effect in murine colon adenocarcinoma and melanoma cancer modelsAn efficient method for in vitro gene delivery via regulation of cellular endocytosis pathway.
P2860
Q26765373-3356C78B-9E07-4C37-B0B2-59BD19704EF6Q26766232-3F1DD18A-37C8-43F3-A688-9D709D1EA69BQ26771342-3429572D-DECE-4CFA-BC11-3EBD70822644Q26777286-E6E65EDB-628C-4812-8D8A-8B793BF3AB75Q26785346-56C35C9B-35DF-489C-BA08-88B94E1D5721Q26799437-7F8E4A6E-F51E-42A6-A200-97F087B4EDD9Q26801077-A89010BB-6C99-4CDA-9D36-AA33532F7C9EQ26825575-E0C6AA80-523C-4260-957F-4D5DE175C75AQ26865726-7F1D01A5-54A8-49AB-8055-65B6E5234F10Q26994703-58A229A8-EA40-46C1-A1A4-3204E45D26D4Q27346564-F9063A92-3CE2-471D-8410-5D524F46301BQ28085748-F32EF2EF-1334-476E-9647-3C59E179893DQ28087380-EC89555C-4E18-4605-BA06-71BC8629E562Q28727481-96F58043-3269-4B82-96D0-9C3924806431Q30381138-643C310E-E41A-419D-8C36-DAFFCA63A24FQ30409171-142C6EED-CE3E-4F39-9FB3-09A3B779983DQ30424435-A7A89F58-9431-4DAA-BF5F-9AA466D61919Q33413888-D96DA222-FFB1-429F-8F5E-4A929F15323CQ33630008-E2CADD32-8617-453D-ABF0-0C2D5E942C52Q33635355-6F6B5473-DA05-456E-9D01-56E26E542EC2Q33652566-77D29B95-DB22-454E-A975-CD86B827EA80Q33792967-E34DCF2B-6AEB-4A02-80FB-4E26E1E2E9D4Q33829707-7B2448CA-2F0C-4AE9-99F6-F891B3CF43D9Q33839032-608041BF-BF6C-4E82-8B01-D17CF7B4ED06Q33881920-1BBB9E47-8A43-42EA-B92A-4A27509248F9Q34001530-1CC02535-7F3A-4580-80DC-74B936ACC372Q34003800-493C1E22-1973-4C30-8082-84277B5BF977Q34043628-9A9241A8-5047-448E-B5BC-E360F9BA043CQ34104368-156A3F44-2C41-4D78-AD23-E8EFCC41E1D7Q34120121-5CDDE51F-1405-4B80-85A4-F83BE51A3A7CQ34135640-5DEA7419-0596-4F34-9AF6-4C5F730F630BQ34171679-C72949FE-031B-4D92-B2AC-8B267B3432E1Q34444118-63804D49-9ADE-4DA0-9994-B8BDC4C147A5Q34465859-42519A8C-37A1-4596-BC7C-0D542B71A7E0Q34616158-4383ACA1-7025-4512-8854-B4FE39D5063DQ34664336-F1DE7341-0D5D-499A-BC75-CF0F190C0F2AQ34668309-FCD21393-8AA7-417A-9835-7E769FCE6E02Q34794525-900E58CE-A6BC-46AC-9A68-D4A5ECF341BEQ34904172-38775F95-CF0A-49D3-B20A-BDF115BD04F9Q35162395-4735E2B7-A753-48D3-9615-42610535398B
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
gotara zanistî
@ku-latn
scientific article published on 06 April 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
name
State-of-the-art gene-based therapies: the road ahead.
@en
State-of-the-art gene-based therapies: the road ahead.
@nl
type
label
State-of-the-art gene-based therapies: the road ahead.
@en
State-of-the-art gene-based therapies: the road ahead.
@nl
prefLabel
State-of-the-art gene-based therapies: the road ahead.
@en
State-of-the-art gene-based therapies: the road ahead.
@nl
P356
P1476
State-of-the-art gene-based therapies: the road ahead.
@en
P2093
Mark A Kay
P2888
P304
P356
10.1038/NRG2971
P577
2011-04-06T00:00:00Z
P5875
P6179
1030150959